Oncotarget

VOLUME 9 (2018)

View Archive »

About The Cover

The cover for issue 41 of Oncotarget features Figure 5, "Variant allele frequencies for associated selected genomic alterations," by Tarlock, et al.

Table of Contents

Research Papers

KRAS NRAS and BRAF mutations detected by next generation sequencing and differential clinical outcome in metastatic colorectal cancer MCRC patients treated with first line FIrB/FOx adding bevacizumab BEV to triplet chemotherapy

https://doi.org/10.18632/oncotarget.25180
26279-26290
Abstract  |  PDF  |  Full Text  |  How to cite

Prostate stem cell antigen mRNA in blood is a predictor of survival after radical prostatectomy in patients with highrisk prostate cancer

https://doi.org/10.18632/oncotarget.25207
26291-26298
Abstract  |  PDF  |  Full Text  |  How to cite

Steviol a natural product inhibits proliferation of the gastrointestinal cancer cells intensively

https://doi.org/10.18632/oncotarget.25233
26299-26308
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Deregulation of calcium homeostasis in BcrAbldependent chronic myeloid leukemia

https://doi.org/10.18632/oncotarget.25241
26309-26327
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Histone deacetylase inhibitor trichostatin A sensitises cisplatinresistant ovarian cancer cells to oncolytic adenovirus

https://doi.org/10.18632/oncotarget.25242
26328-26341
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

PSMD4 is a novel therapeutic target in chemoresistant colorectal cancer activated by cytoplasmic localization of Nrf2

https://doi.org/10.18632/oncotarget.25254
26342-26352
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Potent antileukemic activity of a specific cyclindependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia

https://doi.org/10.18632/oncotarget.25293
26353-26369
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Oleanolic acid induces p53dependent apoptosis via the ERK/JNK/AKT pathway in cancer cell lines in prostatic cancer xenografts in mice

https://doi.org/10.18632/oncotarget.25316
26370-26386
Abstract  |  PDF  |  Full Text  |  How to cite

Differential miRNA expression profiling reveals miR2053p to be a potential radiosensitizer for low dose ionizing radiation in DLD1 cells

https://doi.org/10.18632/oncotarget.25405
26387-26405
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

https://doi.org/10.18632/oncotarget.25413
26406-26416
Abstract  |  PDF  |  Full Text  |  How to cite

Distinct ageassociated molecular profiles in acute myeloid leukemia defined by comprehensive clinical genomic profiling

https://doi.org/10.18632/oncotarget.25443
26417-26430
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometrybased glycoproteomics

https://doi.org/10.18632/oncotarget.25449
26431-26452
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process

https://doi.org/10.18632/oncotarget.25458
26453-26465
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Folic acid–conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action

https://doi.org/10.18632/oncotarget.25470
26466-26490
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Hitting two oncogenic machineries in cancer cells: cooperative effects of the multikinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells

https://doi.org/10.18632/oncotarget.25474
26491-26506
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Biologic canine and human intervertebral disc repair by notochordal cellderived matrix: from bench towards bedside

https://doi.org/10.18632/oncotarget.25476
26507-26526
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells

https://doi.org/10.18632/oncotarget.25480
26527-26542
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Characterization and diagnostic application of genomic NPMALK fusion sequences in anaplastic largecell lymphoma

https://doi.org/10.18632/oncotarget.25489
26543-26555
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Hypoxiatargeted gold nanorods for cancer photothermal therapy

https://doi.org/10.18632/oncotarget.25492
26556-26571
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

A novel role of metal response element binding transcription factor 2 at the Hox gene cluster in the regulation of H3K27me3 by polycomb repressive complex 2

https://doi.org/10.18632/oncotarget.25505
26572-26585
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite

Reviews

Prostaglandins in the pathogenesis of kidney diseases

https://doi.org/10.18632/oncotarget.25005
26586-26602
Abstract  |  PDF  |  Full Text  |  How to cite


Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
By using our site you are giving us permission to use cookies. This website collects cookies to deliver a better user experience, and to analyze our website traffic and performance. Personal data is not collected.